Spotlight: Pharmacists in community mental health teams In this ‘Spotlight’ episode of The PJ Pod, we delve into the progress made towards embedding pharmacy support for patients with severe mental illness into community teams.…
Ability to supply naloxone should be expanded to non-registered members of pharmacy team, says negotiator Community Pharmacy England has said that amended legislation should go further than extending the ability to supply naloxone without a prescription to pharmacists and pharmacy technicians.…
Codeine linctus to be reclassified as a prescription-only medicine While codeine linctus is effective for long-term dry cough, the Medicines and Healthcare products Regulatory Agency said “misuse and abuse can have major health consequences”.…
Lithium monitoring and toxicity management Pharmacists across sectors should be able to counsel patients on the recognition and prevention of lithium toxicity.…
Pharmacies to provide ‘dispense and delivery service’ for weight loss management pilots Community pharmacies will be part of a £40m pilot scheme that will run across several integrated care boards in England.…
MHRA warns of dangers of fake weight loss pens after Yellow Card reports The medicines regulator said Ozempic and Saxenda pens have been confirmed as being falsified with insulin in five of the reports.…
Semaglutide reduces cardiovascular events in adults who are overweight by 20%, study finds Trial results show fewer deaths from cardiovascular events, as well as non-fatal heart attacks and strokes, in patients who received semaglutide versus those who received placebo.…
Tirzepatide approved for weight loss treatment by regulator The Medicines and Healthcare products Regulatory Agency has said tirzepatide will be available to patients with obesity, or who are overweight, with weight-related health problems.…
UK regulator seizes 369 potentially fake weight loss pens following reports of hospitalisations The Medicines and Healthcare products Regulatory Agency said the public should consult a healthcare professional qualified to provide semaglutide and liraglutide via prescription.…
Rapid-acting antidepressants face a slow journey to wider use Evidence is mounting for the effectiveness of rapid-acting antidepressants for treatment-resistant depression — but will their use ever take off in the NHS?…